ClotCare: Blood Clots, Stroke, Heart Attack
Saturday, November 23, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Postings on Cox-2 Inhibitors

Postings for Patients & Caregivers Date Posted
Heart attack and stroke protection of aspirin blocked by Ibuprofen and si September 2006
Bextra Pulled from Market & Warnings Added to ALL NSAIDs April 2005
Non-steroidal Anti-inflamatory Drugs (NSAIDs) Receive Greater Scrutiny in January 2005
News on Vioxx and Congressional Hearings October 2004
Stroke and Heart Attack: A Class Effect of COX 2 Inhibitors? October 2004
Merck Pulls Vioxx Due to Heart Attack and Stroke Risk September 2004

Postings for Healthcare Providers Date Posted
A Review of the suggested anti-cancer benefits of warfarin, low-molecular weight heparin, and aspirin February 2014
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants February 2014
Antiplatelet therapy does not need to be stopped before primary care dent December 2006
Heart attack and stroke protection of aspirin blocked by Ibuprofen and si September 2006
Aspirin Resistance: Do we have standardized methods for measurement? September 2005
Bextra Pulled from Market & Warnings Added to ALL NSAIDs April 2005
Non-steroidal Anti-inflamatory Drugs (NSAIDs) Receive Greater Scrutiny in January 2005
Should Rofecoxib (Vioxx) Have Been Withdrawn Years Ago? November 2004
News on Vioxx and Congressional Hearings October 2004
Stroke and Heart Attack: A Class Effect of COX 2 Inhibitors? October 2004
Merck Pulls Vioxx Due to Heart Attack and Stroke Risk September 2004
Vioxx (rofecoxib), but not Celebrex (celecoxib), Significantly Increases May 2004

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Saturday, November 23, 2024